Innovations in CRISPR technology

被引：16
作者：
Brooks, Alexandra K. [1 ]
Gaj, Thomas [1 ]
机构：
[1] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA
来源：
CURRENT OPINION IN BIOTECHNOLOGY | 2018年 / 52卷
关键词：
HOMOLOGY-DIRECTED-REPAIR; MOUSE MODEL; DNA METHYLATION; GENE ACTIVATION; GENOMIC DNA; HUMAN-CELLS; BASE; CAS; SPECIFICITY; TRANSCRIPTION;
D O I：
10.1016/j.copbio.2018.03.007
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
CRISPR-Cas9 is a versatile tool for genome engineering that has revolutionized biotechnology and is poised to impact medicine. Recent advances in the identification of unique CRISPR systems, as well as the re-engineering of the Cas9 protein for expanded function, has enabled the diversification of the CRISPR genome engineering toolbox. In this review, we highlight these innovations and discuss how advances in CRISPR technology can lead to breakthroughs in the field of gene therapy.
引用
收藏
页码：95 / 101
页数：7
相关论文
共 81 条
  • [1] RNA targeting with CRISPR-Cas13
    Abudayyeh, Omar O.
    Gootenberg, Jonathan S.
    Essletzbichler, Patrick
    Han, Shuo
    Joung, Julia
    Belanto, Joseph J.
    Verdine, Vanessa
    Cox, David B. T.
    Kellner, Max J.
    Regev, Aviv
    Lander, Eric S.
    Voytas, Daniel F.
    Ting, Alice Y.
    Zhang, Feng
    [J]. NATURE, 2017, 550 (7675) : 280 - +
  • [2] C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
    Abudayyeh, Omar O.
    Gootenberg, Jonathan S.
    Konermann, Silvana
    Joung, Julia
    Slaymaker, Ian M.
    Cox, David B. T.
    Shmakov, Sergey
    Makarova, Kira S.
    Semenova, Ekaterina
    Minakhin, Leonid
    Severinov, Konstantin
    Regev, Aviv
    Lander, Eric S.
    Koonin, Eugene V.
    Zhang, Feng
    [J]. SCIENCE, 2016, 353 (6299)
  • [3] Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
    Bengtsson, Niclas E.
    Hall, John K.
    Odom, Guy L.
    Phelps, Michael P.
    Andrus, Colin R.
    Hawkins, R. David
    Hauschka, Stephen D.
    Chamberlain, Joel R.
    Chamberlain, Jeffrey S.
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [4] CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons
    Billon, Pierre
    Bryant, Eric E.
    Joseph, Sarah A.
    Nambiar, Tarun S.
    Hayward, Samuel B.
    Rothstein, Rodney
    Ciccia, Alberto
    [J]. MOLECULAR CELL, 2017, 67 (06) : 1068 - +
  • [5] New CRISPR-Cas systems from uncultivated microbes
    Burstein, David
    Harrington, Lucas B.
    Strutt, Steven C.
    Probst, Alexander J.
    Anantharaman, Karthik
    Thomas, Brian C.
    Doudna, Jennifer A.
    Banfield, Jillian F.
    [J]. NATURE, 2017, 542 (7640) : 237 - 241
  • [6] A highly specific SpCas9 variant is identified by in vivo screening in yeast
    Casini, Antonio
    Olivieri, Michele
    Petris, Gianluca
    Montagna, Claudia
    Reginato, Giordano
    Maule, Giulia
    Lorenzin, Francesca
    Prandi, Davide
    Romanel, Alessandro
    Demichelis, Francesca
    Inga, Alberto
    Cereseto, Anna
    [J]. NATURE BIOTECHNOLOGY, 2018, 36 (03) : 265 - +
  • [7] Repair Pathway Choices and Consequences at the Double-Strand Break
    Ceccaldi, Raphael
    Rondinelli, Beatrice
    D'Andrea, Alan D.
    [J]. TRENDS IN CELL BIOLOGY, 2016, 26 (01) : 52 - 64
  • [8] Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3
    Chadwick, Alexandra C.
    Evitt, Niklaus H.
    Lv, Wenjian
    Musunuru, Kiran
    [J]. CIRCULATION, 2018, 137 (09) : 975 - 977
  • [9] In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing
    Chadwick, Alexandra C.
    Wang, Xiao
    Musunuru, Kiran
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (09) : 1741 - +
  • [10] Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/NMETH.3312, 10.1038/nmeth.3312]
123456789